Next Article in Journal
The Emerging Role of Phosphodiesterase Inhibitors in Fragile X Syndrome and Autism Spectrum Disorder
Next Article in Special Issue
From Ototoxicity to Otoprotection: Mechanism and Protective Strategies in Cisplatin Therapy
Previous Article in Journal
LC-MS/MS Method Development and Validation for Clinical Pharmacokinetics and Therapeutic Drug Monitoring of Potassium-Competitive Acid Blocker Vonoprazan-Based Triple Therapy for H. pylori in Human Plasma
Previous Article in Special Issue
Pharmacovigilance Insights into Ibuprofen’s Neuropsychiatric Safety: A Retrospective Analysis of EudraVigilance Reports
 
 
Article

Article Versions Notes

Pharmaceuticals 2025, 18(10), 1506; https://doi.org/10.3390/ph18101506
Action Date Notes Link
article html file updated 13 October 2025 12:01 CEST Update https://www.mdpi.com/1424-8247/18/10/1506/html
article pdf uploaded. 13 October 2025 12:00 CEST Updated version of record https://www.mdpi.com/1424-8247/18/10/1506/pdf
article xml uploaded. 13 October 2025 12:00 CEST Update https://www.mdpi.com/1424-8247/18/10/1506/xml
article xml file uploaded 13 October 2025 12:00 CEST Update -
article html file updated 8 October 2025 12:22 CEST Original file -
article supplementary file uploaded. 8 October 2025 12:20 CEST - https://www.mdpi.com/1424-8247/18/10/1506#supplementary
article pdf uploaded. 8 October 2025 12:20 CEST Version of Record https://www.mdpi.com/1424-8247/18/10/1506/pdf-vor
article xml uploaded. 8 October 2025 12:20 CEST Update -
article xml file uploaded 8 October 2025 12:20 CEST Original file -
Back to TopTop